COMMUNIQUÉS West-GlobeNewswire

-
MSP Recovery Law Firm Secures Major Legal Win for MSP Recovery as Maryland Supreme Court Upholds Validity of Medicare Recovery Assignments for MSP Recovery and Its Healthcare Clients, Paving the Way for Medicare Recovery Rights Being Pursued Against GEICO
12/07/2025 -
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
13/07/2025 -
Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq
11/07/2025 -
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/07/2025 -
4DMT Announces New Employment Inducement Grants
11/07/2025 -
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
11/07/2025 -
Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer
11/07/2025 -
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
11/07/2025 -
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/07/2025 -
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
11/07/2025 -
Safest Steroid for Muscle Growth and Bodybuilding - Clinical Evidence and Safety Behind CrazyBulk's Bulking Steroids
11/07/2025 -
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants
11/07/2025 -
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion
11/07/2025 -
Rakovina Therapeutics Congratulates Partner - Variational AI for Winning LifeSciencesBC’s 2025 Emerging Biotech Company of the Year Award
11/07/2025 -
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy
11/07/2025 -
Valneva annonce la levée de la restriction temporaire de l'Agence européenne des médicaments sur l'utilisation du vaccin contre le chikungunya IXCHIQ® chez les personnes âgées
11/07/2025 -
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
11/07/2025 -
Milestone Pharmaceuticals Announces Proposed Public Offering
11/07/2025 -
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
11/07/2025
Pages